Cynosure, Inc. (NASDAQ: CYNO) said Tuesday it received Food and Drug Administration 510(k) approval to market a new Laser Delivery System for PicoSure, the world's first aesthetic picosecond laser.
WESTFORD, Mass., Sept. 17, 2015 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today ...
CHISWICK, England, March 31, 2022 /PRNewswire/ -- Cynosure are launching the PicoSure® Pro system at the AMWC Congress in Monaco this weekend, and will be hosting a standalone launch symposium, led by ...
WESTFORD, Mass., July 29, 2013 /PRNewswire/ -- Cynosure, Inc. , a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that it ...
If she had a car before in the form of RevLite, she now has a flying car in the form of PicoSure, said to be the fastest, safest and most advanced laser machine used to treat common skin problems like ...
VANCOUVER, BC--(Marketwired - September 30, 2014) - In honor of National Breast Cancer Awareness Month and to commemorate breast cancer survivors and their courageous battles, Dr Sachit Shah is ...
Cynosure Inc. CYNO recently announced the receipt of FDA approval for marketing a new Laser Delivery System (LDS) for PicoSure, the world's first aesthetic picosecond laser. The new 1064 nm Laser ...
Cynosure, Inc. (NASDAQ: CYNO) today announced FDA 510(k) clearance of its new 532 nm Laser Delivery System for PicoSure®, creating a powerful, dual-wavelength laser system for removing tattoos of all ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cynosure announced today that the FDA has granted 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results